Vimarsana
Biggest News Aggregation in the World

Page 6 - Gentofte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gentofte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gentofte Today - Breaking & Trending Today

Year in Review: Obesity - Vimarsana News

Year in Review: Obesity

2023 highlights included new FDA approvals, more drugs in development, and a pivot away from BMI

1 in 4 has alarmingly few intestinal bacteria - Vimarsana News

1 in 4 has alarmingly few intestinal bacteria

Contact: Oluf Pedersen oluf@sund.ku.dk 45-52-39-56-50 University of Copenhagen All people have trillions of bacteria living in their intestines. If you place them on a scale, they weigh around 1.5 kg. Previously, a major part of these 'blind passengers' were unknown, as they are difficult or impossible to grow in laboratories. But over the past five…

Yokogawa Electric : Completes Installation of High-Performance Combustion Control Solution at Poland's Largest Waste-to-Energy Plant -October 23, 2023 at 11:07 pm EDT - Vimarsana News

Yokogawa Electric : Completes Installation of High-Performance Combustion Control Solution at Poland's Largest Waste-to-Energy Plant -October 23, 2023 at 11:07 pm EDT

Tokyo, Japan - October 24, 2023 Yokogawa Electric Corporation announces that Yokogawa Poland has completed installation of the FuzEventâ„¢ combustion control...

PowerGo Quickly Expands Charging Network in Denmark - Vimarsana News

PowerGo Quickly Expands Charging Network in Denmark

PowerGo installs around 1600 public charging points for electric vehicles (EV’s) in Denmark over the next two years, making an important contribution to the roll-out of the European charging network.

Patients With Psoriasis Lose Weight With Roflumilast: Study - Vimarsana News

Patients With Psoriasis Lose Weight With Roflumilast: Study

Oral roflumilast not only appears to improve skin symptoms, but it could also help with weight loss, results of the phase 2 PSORRO study suggest.